R.E.M.S. technology reaches the oceanic continent.
We are proud to announce the achievement of sales authorization for the Echolight products issued by the Australia Government Department of Health. So Australia is also opening its doors to R.E.M.S. (Radiofrequency Echographic Multi Spectrometry) bringing the presence of Echolight to over 40 countries around the world.
R.E.M.S. is the innovative technology running the operation of the EchoS densitometer which performs in a few minutes an ultrasound scan of the bone without radiation, delivers the report in real time being able to check the bone health status and then reduce the risk of fragility fracture, as a consequence of osteoporosis.
Being now used in hundreds of hospitals and clinical centers around the world, the device is also available in Australia thanks to the collaboration with an important local partner with the purpose of introducing a new concept of bone health, based on prevention, early diagnosis and bone structure monitoring
Echolight in Official National Guidelines
New important recognition for Echolight: REMS technology (Radiofrequency Echographic Multi Spectrometry), the first ultrasound-based method to diagnose the osteoporosis and assess the risk of fragility fractures, is officially included in the Inter-Company Ministerial...
ASBMR: Bone research makes a stop in California
Echolight took part in the annual convention of the American Society for Bone and Mineral Research (ASBMR) in San Diego, California. This eagerly awaited meeting took place from 1st to 4th October 2021 and that involved more than 3,000 experts from all over the world...
Echolight awarded Vizient contract
Echolight Medical awarded Vizient contract to provide improved technology in bone density diagnostics. Echolight Medical, an innovator in bone health technology, has been awarded a multi-year contract with Vizient Inc,, to make its Radiofrequency Echographic Multi...
